Union Health Minister J. P. Nadda on Sunday, June 14, 2026, took to X to catalogue what the government describes as sweeping achievements in India's healthcare sector over the past 12 years under Prime Minister Narendra Modi, citing expansion of premier medical institutions, digital health infrastructure, and India's growing role as a global pharmaceutical supplier.

Context

Posting under the hashtag #12YearsOfSwasthBharat, Nadda credited Modi's 'visionary leadership' for what he described as a 'comprehensive expansion' of health services — from COVID-19 management to the development of quality treatment facilities. The post arrives as the ruling BJP marks over a decade in government and seeks to consolidate its health-sector narrative ahead of future electoral cycles.

Nadda stated that the number of AIIMS (All India Institutes of Medical Sciences) in the country has grown from 8 to 23 in the past 12 years, adding premier tertiary-care capacity to states that previously had none. This expansion was anchored in the Pradhan Mantri Swasthya Suraksha Yojana, under which new AIIMS campuses were announced from 2015 onward.

Policy Backdrop

The minister highlighted that the government's telemedicine platform eSanjeevani has facilitated more than 42 crore teleconsultations, a figure that reflects the platform's aggressive scaling during and after the COVID-19 pandemic. More than 43 crore Ayushman Bharat cards have been issued, the post states, providing financial protection of up to Rs 5 lakh per family per year to crores of vulnerable households under the Pradhan Mantri Jan Arogya Yojana launched in 2018.

Nadda also pointed to 90 crore-plus digital health records, more than 19,000 Jan Aushadhi Kendras supplying affordable generic medicines, and the Ayushman Vay Vandana Yojana as measures that have made healthcare 'more accessible, affordable and people-centric.' The Pradhan Mantri Jan Aushadhi Yojana was relaunched and significantly scaled after 2014, with the kendra network expanding to reach smaller towns and rural areas.

Stakeholders and Impact

The primary beneficiaries of these programmes are low-income families and rural patients who previously faced high out-of-pocket healthcare expenditure. The Ayushman Bharat scheme specifically targets households at the bottom of the economic pyramid, while Jan Aushadhi Kendras cut medicine costs sharply against branded equivalents.

Nadda's post also underscored India's global pharmaceutical footprint, asserting that the country supplies 70% of the world's antiretroviral medicines, meets 55–60% of UNICEF's vaccine requirements, and accounts for nearly 20% of global generic medicine supply. These figures position India as what Nadda called an 'important player in the global health sector,' reinforcing the government's 'pharmacy of the world' branding for domestic manufacturers.

What's Next

Attention will now turn to the further operationalisation of newly built AIIMS campuses, potential expansions of Ayushman Bharat coverage in the upcoming health budget, and parliamentary scrutiny of digital health data protection rules governing the 90 crore-plus health records now held on government platforms.

With India's healthcare transformation framed as the foundation of a 'healthy, empowered and developed India,' the government's next policy signals on funding, staffing of new institutions, and insurance coverage limits will determine whether the momentum highlighted in Nadda's post translates into measurable improvements in health outcomes for the country's most vulnerable citizens.